343
edits
Min-Ho Kim Lab:Lab Members: Difference between revisions
From OpenWetWare
Jump to navigationJump to search
no edit summary
Min-Ho Kim (talk | contribs) No edit summary |
Min-Ho Kim (talk | contribs) No edit summary |
||
| Line 45: | Line 45: | ||
<h3>Eric Dyne, Ph.D candidate in School of Biomedical Sciences</h3> | <h3>Eric Dyne, Ph.D candidate in School of Biomedical Sciences</h3> | ||
<font size=3> | <font size=3> | ||
Eric has studied neurodegeneration since the beginning of his Ph.D. program after finishing his Bachelor's degree in Biological Sciences at Kent State University. The focus of his research is to develop nanotherapeutics for targeting toxic Aβ plaques via minimally invasive manner towards the treatment of AD/ADRD. | Eric has studied neurodegeneration since the beginning of his Ph.D. program after finishing his Bachelor's degree in Biological Sciences at Kent State University. The focus of his research is to develop nanotherapeutics for targeting toxic Aβ plaques and microglia via minimally invasive manner towards the treatment of AD/ADRD. | ||
</font> | </font> | ||
|} | |} | ||
| Line 57: | Line 57: | ||
[[Image:Alhussain_photo.JPG||120px]] | [[Image:Alhussain_photo.JPG||120px]] | ||
Hussain joined Kim lab in January 2019. He is currently in the Ph.D program in the school of Biomedical Sciences at Kent State University. He has B.Sc. in Medical Laboratory and MSc. in Biomedical Sciences- specialization in Medical & Molecular Immunology. The focus of his research is to develop nanotherapeutics for targeting macrophages towards the resolution of biofilm infections. | |||
</font> | </font> | ||
